Searched for
MIKE DOUSTDAR
School Assembly News Headlines, August 6, 2026: Top national, international, business, sports updates and thought of the daySchool Assembly News Headlines: The Lok Sabha in India has successfully passed a significant bill aimed at modernizing banking evidence law...- Novo CEO says setbacks demand faster research, acquisitions as investors fret over pipelineNovo Nordisk CEO Mike Doustdar said the company will speed up research and pursue smaller acquisitions to strengthen its drug pipeline afte...
- CEOs are getting ruthless about worker performanceCorporate leaders are increasingly prioritizing results over employee comfort, with CEOs like Unilever's Fernando Fernandez demanding "volu...
- Why did NVO stock crash over 14% today? Novo Nordisk’s weight-loss drug CagriSema misses trial goal against Eli Lilly’s TirzepatideNVO stock today: Novo Nordisk shares plummeted after its next-generation weight loss drug, CagriSema, failed to achieve non-inferiority in ...
- Novo Nordisk shares jump 10% after US approves Wegovy pillNovo Nordisk shares jumped 10% on Tuesday after the U.S. Food and Drug Administration approved its weight-loss pill, giving the Danish dru...
- Take a pill! Novo Nordisk's Wegovy gets US' nod as daily pill for obesity treatmentNovo Nordisk's popular weight-loss drug Wegovy is now available as a pill in the US. The US Food and Drug Administration has approved the o...
- Novo Nordisk says Alzheimer's drug trial fails to meet main goalNovo Nordisk's Alzheimer's drug trials have ended without success. The semaglutide pill did not slow the brain disease's progression. This ...
- Pfizer to acquire obesity drug startup Metsera in $10 billion dealPfizer has agreed to acquire obesity drug developer Metsera for up to $86.25 a share, surpassing Novo Nordisk's final offer. This move mark...
- Novo Nordisk's top investor seizes board controlIn a bold push for greater influence, a key investor in Novo Nordisk is advocating for a complete overhaul of the board. This strategic man...
- Novo Nordisk hires US pharma veteran as Trump pricing pressure mountsNovo Nordisk has appointed Greg Miley, a U.S. pharmaceutical executive, as its new global head of corporate affairs. This move comes as the...
- Wegovy-maker Novo Nordisk starts 'fight back' as investors returnNovo Nordisk aims to regain its position in the weight-loss drug market. The company's shares are rising after a restructuring plan. CEO Mi...
- Novo Nordisk to cut 9,000 jobs in restructuringNovo Nordisk, the maker of Wegovy, plans a major restructuring. The company will cut 9,000 jobs globally. This move aims to save 8 billion ...
- Riding high on Wegovy, Novo Nordisk doubled its workforce. Now layoffs loomNovo Nordisk faces potential layoffs after a period of rapid expansion fueled by the success of Wegovy. The company's workforce nearly doub...
- Drugmaker Novo Nordisk freezes hiring for non-critical jobsNovo Nordisk, the maker of Wegovy, has initiated a global hiring freeze for non-critical roles amid increasing competition and pressure fro...
- Wegovy maker Novo Nordisk to reduce costs after $95 billion stock lossWegovy-maker Novo Nordisk said on Wednesday it will sharpen its commercial focus and reduce costs, after a major profit warning and new CEO...
- Wegovy maker Novo Nordisk to reduce costs after $95 billion stock lossNovo Nordisk, the maker of Wegovy, will focus on commercial strategy and cost reduction. This decision follows a profit warning and a chang...
- Wegovy maker Novo's profit warning triggers $70 billion share routNovo Nordisk's market value plummeted by $70 billion following a profit warning and the appointment of Maziar Mike Doustdar as the new CEO....
- Novo Nordisk stock plunges 23% after cutting sales forecast and naming Mike Doustdar as new CEONVO stock today: Novo Nordisk's stock plummeted over 23% following a reduced full-year sales forecast and the announcement of Maziar Mike D...
- Shiba Inu’s big comeback? 3,000% jump could make it the new king of meme coins by 2026Shiba Inu price prediction 2026: Shiba Inu is gaining traction, with experts predicting a potential 3,000% surge, possibly surpassing Dogec...
- Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar as new CEONovo Nordisk has a new CEO. Maziar Mike Doustdar takes the helm. This follows the departure of Lars Fruergaard Jorgensen. The company aims ...
Load More
